Recent REPROCELL News

REPROCELL News

Author: Dr David Bunton

CEO, REPROCELL Europe Ltd.

REPROCELL is pleased to announce that the first patient has been registered and the test article administered at Nagoya University in the Phase II clinical trial of the regenerative medicine product Stemchymal®.

Continue reading →

Clinical Capabilities


Recent REPROCELL News